GL1X · GenesisL1 explorer

MolNFT v1 · #123317 · protein

Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 10

5JGB · TAK1 kinase - TAB1 chimera fusion protein: “Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 10”. X-ray diffraction, 1 ligand (6JV), 4 pockets (best druggability 0.60). MolNFT v1 #123317 on GenesisL1: 3D…

PDB
5JGB
Type
protein
Length
295 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
TAK1 kinase - TAB1 chimera fusion protein
EC
2.7.11.25
UniProt
O43318, Q15750
Ligands
6JV
Pockets
4 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATAK1 kinase - TAB1 chimera fusion protein (EC 2.7.11.25)protein29540% helix, 17% strandO43318, Q15750

Ligands and binding sites

  • 6JV · N-(2-methoxy-4-{[3-(4-methylpiperazin-1-yl)propyl]carbamoyl}phenyl)-4-oxo-3,4-dihydrothieno[3,2-d]pyrimidine-7-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11650.600.83266JV
2670.330.7523empty
3590.310.7618empty
4520.270.7417empty

Compared structures

  • 5JGB · Crystal structure of human TAK1/TAB1 fusion protein in complex with ligand 10 · the same entry in another collection · chain A against A, TM-score 1.00
  • O43318 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase kinase kinase 7… · a predicted model of the same protein · chain A against A, TM-score 0.93
  • Q15750 · AlphaFold monomer V2.0 prediction for TGF-beta-activated kinase 1 and MAP3K7-binding… · a predicted model of the same protein · chain A against A, TM-score 0.29

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.